Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus

BACKGROUND: The apolipoprotein B/A1 (apoB/A1) ratio is a stronger predictor of future cardiovascular disease than is the level of conventional lipids. Statin and ezetimibe combination therapy have shown additional cardioprotective effects over statin monotherapy. METHODS: This was a single-center, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, You-Cheol, Jun, Ji Eun, Jeong, In-Kyung, Ahn, Kyu Jeung, Chung, Ho Yeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834829/
https://www.ncbi.nlm.nih.gov/pubmed/30688048
http://dx.doi.org/10.4093/dmj.2018.0124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834829/
https://www.ncbi.nlm.nih.gov/pubmed/30688048
http://dx.doi.org/10.4093/dmj.2018.0124

Ejemplares similares